Insulin Icodec

Insulin icodec, marketed as Awiqli, is a groundbreaking once-weekly basal insulin designed to simplify diabetes management by drastically reducing the number of required injections. Through its unique ability to bind to albumin, the medication maintains a long half-life of approximately eight days, providing steady glucose control for an entire week.